Author

I. Todeschini

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:proteomics· 2 Organism:bacteria (other)· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:host-pathogen & immune response· 1 Assay:metabolomics· 1 Organism:zebrafish· 1

Frequent Co-Authors

C. S. Farah· 2 shared A. C. Neto· 1 shared A. C. Perez· 1 shared A. D. da Purificacao· 1 shared A. Inague· 1 shared A. M. Garnique· 1 shared A. P. Barbosa· 1 shared B. H. V. Fernandes· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

C. S. Farah

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Resource sharing by outer membrane vesicles from a citrus pathogen

G. G. Araujo, M. M. Conforte, A. D. da Purificacao, I. Todeschini, E. E. Llontop, C. B. Angeli, A. Inague, M. Y. Yoshinaga, R. F. de Souza, R. Papai, M. S. Luz, S. Miyamoto, G. Palmisano, C. S. Farah, C. R. Carvalho

This study identifies outer membrane vesicles from Xanthomonas citri as resource-sharing structures containing nutrients and enzymes that support bacterial growth and virulence.

bioRxiv · Apr 26, 2021 · PreprintMicrobiology

Zebrafish studies on the vaccine candidate to COVID-19, the Spike protein: Production of antibody and adverse reaction

B. H. V. Fernandes, N. M. Feitosa, A. P. Barbosa, C. G. Bomfim, A. M. Garnique, F. I. Gomes, R. T. Nakajima, M. A. Belo, S. F. Eto, D. C. Fernandes, G. Malafaia, W. G. Manrique, G. Conde, R. R. Rosales, I. Todeschini, , Veras

This study uses zebrafish to test a COVID-19 vaccine candidate, showing antibody production and adverse reactions similar to human severe cases.

bioRxiv · Oct 20, 2020 · PreprintImmunology